„ExCEEd Orphan and Neobiomics are happy to announce the first sales of ProPrems® in the Czech Republic and Hungary!
This means that ProPrems® is now used as a safe food supplement for infants in ten countries within Europe. With an increasing interest in the unique features of ProPrems®, we are confident that other countries within Central & Eastern Europe will follow soon!”
Neobiomics AB, founded in 2016 by Stefan Johansson and Philipp Novak, is an alumni member of the Innovation Incubator at Karolinska Institutet Innovation AB. The first product ProPrems® is a high-quality multi-strain food supplement manufactured by Chr. Hansen, a world-wide leader in manufacturing bacterial cultures. ProPrems® is now available in a majority of European countries and continues its geographical expansion within Europe.
About ExCEEd Orphan s.r.o.
ExCEEd Orphan s.r.o. was founded in 2018 by 5 rare disease experts from multiple CEE countries. The company is focusing on innovative treatments for rare diseases and has extensive experience in launching innovative medicines in this field. The portfolio of ExCEEd Orphan includes products in therapeutic areas like hematology, neurology, immunology, and metabolic diseases.
For further information, please refer to www.neobiomics.eu and www.exceedorphan.com